(S (NP-SBJ (NP Lymphocytes/NNS) (PP from/IN (NP CML/NN patients/NNS))) (VP lack/VBP (NP (NP a/DT (ADJP 47/CD kDa/NN) factor/NN) (VP having/VBG (NP (NP affinity/NN) (PP for/IN (NP a/DT genomic/JJ sterol/NN regulatory/JJ sequence/NN)))))) ./.)
(S (NP-SBJ-9 Deranged/VBN cellular/JJ cholesterol/NN homeostasis/NN) (VP has/VBZ (VP been/VBN (ADVP widely/RB) (VP recognized/VBN (NP *-9/-NONE-) (PP in/IN (NP (NP the/DT (NP-COOD (NP initiation/NN) (CONJP as/RB well/RB as/IN) (NP progression/NN))) (PP of/IN (NP (NP various/JJ types/NNS) (PP of/IN (NP cancers/NNS)) (PP including/VBG (NP (NP chronic/JJ myeloid/JJ leukaemia/NN) (PRN -LRB-/-LRB- (NP CML/NN) -RRB-/-RRB-)))))))))) ./.)
(S (SBAR Since/IN (S (NP-SBJ-10 the/DT human/JJ genomic/JJ (NP (NP sterol/NN regulatory/JJ element/NN) (PRN -LRB-/-LRB- (NP SRE/NN) -RRB-/-RRB-))) (VP has/VBZ (VP been/VBN (VP shown/VBN (S (NP-SBJ *-10/-NONE-) (VP to/TO (VP regulate/VB (NP (NP various/JJ key/JJ genes/NNS) (VP involved/VBN (NP */-NONE-) (PP in/IN (NP this/DT phenomenon/NN)))))))))))) ,/, (NP-SBJ the/DT present/JJ study/NN) (VP revealed/VBD (NP-COOD (NP (NP the/DT existence/NN) (PP of/IN (NP (NP a/DT unique/JJ (ADJP 47/CD kDa/NN) protein/NN factor/NN) (VP having/VBG (NP (NP affinity/NN) (PP for/IN (NP this/DT SRE/JJ sequence/NN)))))) (PP in/IN (NP (NP lymphocytes/NNS) (PP from/IN (NP normal/JJ subjects/NNS))))) ,/, (CONJP as/RB well/RB as/IN) (NP (NP its/PRP$ absence/NN) (PP in/IN (NP (NP lymphocytes/NNS) (PP from/IN (NP untreated/JJ CML/NN patients/NNS))))))) ./.)
(S (ADVP However/RB) ,/, (NP-SBJ this/DT factor/NN) (VP appeared/VBD (SBAR-TMP (WHADVP-11 when/WRB) (S (NP-SBJ these/DT CML/NN patients/NNS) (VP achieved/VBD (NP (NP complete/JJ haematological/JJ remission/NN) (PRN -LRB-/-LRB- (NP CHR/NN) -RRB-/-RRB-)) (PP through/IN (NP alpha-interferon/NN therapy/NN)) (ADVP *T*-11/-NONE-))))) ./.)
(S (ADVP Furthermore/RB) ,/, (NP-SBJ-12 an/DT inverse/JJ relationship/NN) (VP was/VBD (ADVP also/RB) (VP observed/VBN (NP *-12/-NONE-) (PP between/IN (NP-COOD (NP (NP the/DT LDL/NN receptor/NN gene/NN expression/NN) (PP at/IN (NP the/DT transcriptional/JJ level/NN))) and/CC (NP (NP the/DT binding/NN affinity/NN) (PP of/IN (NP this/DT (ADJP 47/CD kDa/NN) protein/NN factor/NN)) (PP to/TO (NP the/DT SRE/NN sequence/NN))))))) ./.)
(S (PP Based/VBN (PP upon/IN (NP these/DT results/NNS))) (NP-SBJ we/PRP) (VP propose/VBP (SBAR that/IN (S (NP-SBJ this/DT factor/NN) (VP may/MD (VP have/VB (NP a/DT role/NN) (PP in/IN (NP (NP pathophysiology/NN) (PP of/IN (NP chronic/JJ myeloid/JJ leukaemia/NN))))))))) ./.)
